BIO, BVGH and Gates Foundation to Sponsor Partnering for Global Health Forum 2008
WASHINGTON, D.C. (December 5, 2007) -- The Biotechnology Industry Organization (BIO), BIO Ventures for Global Health (BVGH) and the Bill & Melinda Gates Foundation will co-sponsor the Partnering for Global Health Forum 2008, to be held March 10-12 in Washington, DC. The international partnering meeting will focus on opportunities for the biotechnology industry to help accelerate the development of medicines for neglected diseases of the developing world.
“Biotechnology holds the key to drug development for neglected diseases. Through this meeting we are opening up a dialogue to fully realize the enormous potential for biotech to help to save and transform lives in developing countries,” said Jim Greenwood, president and CEO of BIO.
Attendees will address the pressing needs for innovation and explore new avenues for progress through lessons learned, market incentives, innovative business models and potential partnership meetings.
"The Partnering for Global Health Forum will bring together leaders in industry and global health to discuss how biotech’s assets can best be leveraged to address the global health innovation gap and create the next generation of medicines for developing world diseases," said BVGH President and CEO Dr. Christopher D. Earl.
The Forum will feature:
· An open exchange with world-renowned leaders in global health, industry, government and the donor community
· Opportunities to meet one-on-one with leading companies, researchers, donors and investors
· Presentations from innovators pursuing technologies and products applicable to diseases of the developing world
· Perspectives from public and private funders supporting global health R&D
“Biotechnology companies have an essential role to play in global health,” said Dr. Tachi Yamada, president of the Gates Foundation’s Global Health Program. “We hope this partnering meeting will help more companies get involved in research to fight the world’s most serious and neglected diseases.”
Hyatt Regency Reston
1800 Presidents Street
Reston, VA 20190
For more information go to pghforum.org
BIO Ventures for Global Health (BVGH), a non-profit organization, is harnessing the resources of the biotechnology industry to create new medicines for neglected diseases of the developing world. Our mission is to break down barriers that hinder industry involvement in global health product development and to catalyze new industry investment. www.bvgh.org
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the annual BIO International Convention, the world’s largest gathering of the biotechnology industry.
Upcoming BIO Events
BIO-Asia Partnering Conference
January 28-29, 2008
BIO CEO & Investor Conference
February 11-13, 2008
New York, NY
BIO-Europe Spring 2008
April 7-9, 2008
World Congress on Industrial Biotechnology & Bioprocessing
April 27-30, 2008
2008 BIO International Convention
June 17-20, 2008
San Diego, Calif.
Visit www.bio.org for more information on BIO and all upcoming events.